The percentage of muscle tissue disruption assessed from MRI cross-sectional scans of the midthigh at D3 and D6 were 23 8 and 16 5% for LCLT and 39 5 and 29 6% for placebo, respectively
Among those who used a GLP-1 or GLP-1/GIP medication for weight loss in the past year, 85.0% [79.390.7%] used a medication licensed for weight loss in Great Britain69.5% [62.067.0%] reported using Mounjaro, 20.0% [12.927.0%] Wegovy, and 3.3% [0.06.8%] Saxenda (note that participants could select multiple medications, so these values sum to more than the total
ALT levels significantly decreased following treatment with glutathione for 4 months
Capsules were packaged in pill boxes that were tagged A and B for blinding
Anti-inflammatory cytokines and risk of type 2 diabetes
At 10mg/mL concentration, each 0.01mL increment represents 100mcg, which introduces 2040% relative error for protocols requiring 250mcg doses